[go: up one dir, main page]

BR9007769A - PREPARATION FOR THE TREATMENT OF OTHERS TISSUE, PROCESS FOR THE PREPARATION OF EX-VIVO OTHERS TISSUE BEFORE TRANSPLANTATION OR THEIR USE AS A CURING MATERIAL, PROCESS FOR THE TREATMENT OF A PATIENT, AND, PROCESS FOR PERFORMING ALLOGENIC OR XENOGENIC ORGAN ORGAN TRANSPLANTS A HUMAN PATIENT, OR TO PROVIDE ALLOGENIC OR XENOGENIC DRESSING TO THIS PATIENT - Google Patents

PREPARATION FOR THE TREATMENT OF OTHERS TISSUE, PROCESS FOR THE PREPARATION OF EX-VIVO OTHERS TISSUE BEFORE TRANSPLANTATION OR THEIR USE AS A CURING MATERIAL, PROCESS FOR THE TREATMENT OF A PATIENT, AND, PROCESS FOR PERFORMING ALLOGENIC OR XENOGENIC ORGAN ORGAN TRANSPLANTS A HUMAN PATIENT, OR TO PROVIDE ALLOGENIC OR XENOGENIC DRESSING TO THIS PATIENT

Info

Publication number
BR9007769A
BR9007769A BR909007769A BR9007769A BR9007769A BR 9007769 A BR9007769 A BR 9007769A BR 909007769 A BR909007769 A BR 909007769A BR 9007769 A BR9007769 A BR 9007769A BR 9007769 A BR9007769 A BR 9007769A
Authority
BR
Brazil
Prior art keywords
patient
preparation
treatment
xenogenic
allogenic
Prior art date
Application number
BR909007769A
Other languages
Portuguese (pt)
Inventor
Herman Waldmann
Kenneth Ian Welsch
Michael Gordon Thick
David Hirsch Taube
Geoffrey Hale
Original Assignee
Lynxvale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898923712A external-priority patent/GB8923712D0/en
Application filed by Lynxvale Ltd filed Critical Lynxvale Ltd
Publication of BR9007769A publication Critical patent/BR9007769A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR909007769A 1989-10-20 1990-10-22 PREPARATION FOR THE TREATMENT OF OTHERS TISSUE, PROCESS FOR THE PREPARATION OF EX-VIVO OTHERS TISSUE BEFORE TRANSPLANTATION OR THEIR USE AS A CURING MATERIAL, PROCESS FOR THE TREATMENT OF A PATIENT, AND, PROCESS FOR PERFORMING ALLOGENIC OR XENOGENIC ORGAN ORGAN TRANSPLANTS A HUMAN PATIENT, OR TO PROVIDE ALLOGENIC OR XENOGENIC DRESSING TO THIS PATIENT BR9007769A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42474889A 1989-10-20 1989-10-20
GB898923712A GB8923712D0 (en) 1989-10-20 1989-10-20 Compounds and methods for the amelioration of graft rejection
PCT/GB1990/001621 WO1991005568A1 (en) 1989-10-20 1990-10-22 Materials and methods for the treatment of foreign tissue

Publications (1)

Publication Number Publication Date
BR9007769A true BR9007769A (en) 1992-08-11

Family

ID=26296086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007769A BR9007769A (en) 1989-10-20 1990-10-22 PREPARATION FOR THE TREATMENT OF OTHERS TISSUE, PROCESS FOR THE PREPARATION OF EX-VIVO OTHERS TISSUE BEFORE TRANSPLANTATION OR THEIR USE AS A CURING MATERIAL, PROCESS FOR THE TREATMENT OF A PATIENT, AND, PROCESS FOR PERFORMING ALLOGENIC OR XENOGENIC ORGAN ORGAN TRANSPLANTS A HUMAN PATIENT, OR TO PROVIDE ALLOGENIC OR XENOGENIC DRESSING TO THIS PATIENT

Country Status (8)

Country Link
EP (1) EP0496806A1 (en)
JP (1) JPH05501256A (en)
AU (1) AU631272B2 (en)
BR (1) BR9007769A (en)
CA (1) CA2069342A1 (en)
FI (1) FI921746A0 (en)
OA (1) OA09658A (en)
WO (1) WO1991005568A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595911A (en) * 1990-03-14 1997-01-21 Cold Spring Harbor Laboratory Isolation of a cDNA encoding a protein tyrosine phosphatase which localizes to focal adhesions
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6197298B1 (en) 1991-04-19 2001-03-06 Tanox, Inc. Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
US6129916A (en) * 1991-04-19 2000-10-10 Tanox, Inc. Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
US6106835A (en) * 1991-04-19 2000-08-22 Tanox, Inc. Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
US5872222A (en) * 1991-04-19 1999-02-16 Tanox Biosystems, Inc. Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
CA2121235A1 (en) * 1991-10-18 1993-04-29 Hirsch D. Taube In vitro antibody perfusion of kidney grafts
US6024957A (en) * 1993-06-02 2000-02-15 Research Corporation Technologies, Inc. Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
US6106834A (en) 1993-06-02 2000-08-22 Research Corporation Technologies, Inc. Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
ATE226437T1 (en) * 1993-06-10 2002-11-15 Univ Wake Forest (PHOSPHO)LIPIDS TO FIGHT HEPATITIS B INFECTION
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201601073D0 (en) * 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
WO2022079199A1 (en) * 2020-10-15 2022-04-21 UCB Biopharma SRL Binding molecules that multimerise cd45

Also Published As

Publication number Publication date
OA09658A (en) 1993-05-15
CA2069342A1 (en) 1991-04-21
WO1991005568A1 (en) 1991-05-02
EP0496806A1 (en) 1992-08-05
FI921746A7 (en) 1992-04-16
FI921746L (en) 1992-04-16
AU6623590A (en) 1991-05-16
AU631272B2 (en) 1992-11-19
FI921746A0 (en) 1992-04-16
JPH05501256A (en) 1993-03-11

Similar Documents

Publication Publication Date Title
BR9007769A (en) PREPARATION FOR THE TREATMENT OF OTHERS TISSUE, PROCESS FOR THE PREPARATION OF EX-VIVO OTHERS TISSUE BEFORE TRANSPLANTATION OR THEIR USE AS A CURING MATERIAL, PROCESS FOR THE TREATMENT OF A PATIENT, AND, PROCESS FOR PERFORMING ALLOGENIC OR XENOGENIC ORGAN ORGAN TRANSPLANTS A HUMAN PATIENT, OR TO PROVIDE ALLOGENIC OR XENOGENIC DRESSING TO THIS PATIENT
DE59209658D1 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF Wounds, SCARS AND KELOIDS
BR9306375A (en) Replacement of live skin and processes for its production and use of cell-coated microspheres
NO170194C (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE HEALTH SUBSTANCES
Lawrence What materials for dressings?
SE9602226D0 (en) Biocompatible glue
ATE196604T1 (en) COMPOSITION CONTAINING PDGF AND DEXAMETHASON FOR PROMOTING TISSUE REPAIR AND REGENERATION
DE3851203D1 (en) Use of GHL-Cu derivatives in the manufacture of a medicament to stimulate hair growth.
DE3855220D1 (en) METHOD FOR ELIMINATING INFECTIOUS AGENTS IN TISSUE
BR9206736A (en) Composition to affect the growth of living tissue in mammals Processes to promote angiogenesis in mammals to treat transplanted tissue or organs in mammals and to treat damaged or transplanted bone
BR9301314A (en) EMULSION OF OIL IN WATER SAME USE
ATE97316T1 (en) COSMETIC AGENT AND COMPOSITION FOR TREATMENT OF THE SKIN.
EP0925076B1 (en) Method to produce an implant consisting of an absorbable carrier material containing a medical active substance such as a pharmaceutical substance, an antibiotic, a cytostatic, or a hormone
ES2063250T3 (en) USE OF THROMBOSPONDIN TO FACILITATE HEALING OF WOUNDS.
DE60018409D1 (en) USE OF ANTISEPTICA FOR THE PREPARATION OF MEDICAMENTS FOR THE PROPHYLAXIS AND THE TREATMENT OF INFECTIONS AND / OR FUNCTIONAL TISSUE FORMATIONS IN THE BODY'S INSECTS
ES540447A0 (en) A METHOD OF PREPARING A BANDAGE
AR215499A1 (en) PROCEDURE TO PREPARE POROUS COLLAGEN, FOR APPLICATION IN THE TREATMENT AND CARE OF THE SKIN
ATE11224T1 (en) WOUND HEALING COMPOSITIONS.
ES2118726T3 (en) EPIDERMAL GROWTH FACTOR AS A MEDICATION FOR THE RESTORATION OF NEURONS OF THE NIGRA SUBSTANCE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
ATE136465T1 (en) USE OF GIBBERELLINS IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PROSTATITIS
SE9003311L (en) APPLICATION OF GLYCOPROTEIN, EXCAVATED GRANGE (-) BACTERIA, MANUFACTURE OF COSMETIC OR DERMATOLOGICAL COMPOSITIONS AND COMPOSITIONS INCLUDING THESE GYCOPROTEIN
DD222497A1 (en) STIFF WUNDENBAND, ESPECIALLY WUNDHAUBE
RU94006811A (en) RADIO-HEATING COATING ON THE BASIS OF POLYMER AND ENZYME OF THE CYTOCOL SPONGE
DE3775278D1 (en) TOPICAL METHOTREXATE PREPARATION FOR TREATING HYPERPROLIFERATIVE EPITHELIC DISEASES.
BR9303733A (en) USE OF A COMPOUND, SUBSTANCE OR COMPOSITION, IN THE PREPARATION OF A SUBSTANCE OR COMPOSITION TO TREAT A VIRAL INFECTION, COMPOUND, SUBSTANCE OR COMPOSITION, THEIR USES FOR, TREATMENT OF A VIRAL INFECTION, AS A TREATMENT OR MEDICATION FROM A VIRAL INFECTION; MEDICINE OR MEDICINE, PROCESS OF PREPARING A COMPOUND AND PROCESS OF TREATING A VIRAL INFECTION IN A HUMAN OR ANIMAL BEING

Legal Events

Date Code Title Description
FD3 Appl. lapsed due to non-payment of renewal fee